General Electric’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,111,111
Closed -$2.29M 6
2022
Q4
$2.29M Hold
1,111,111
0.03% 4
2022
Q3
$2.92M Hold
1,111,111
0.05% 5
2022
Q2
$4.02M Hold
1,111,111
0.07% 5
2022
Q1
$8.59M Hold
1,111,111
0.09% 5
2021
Q4
$15.7M Hold
1,111,111
0.14% 5
2021
Q3
$19.5M Buy
+1,111,111
New +$19.5M 0.36% 4

Other funds holding SOPH

General Electric's SOPH Position: Q1 2023 in Review

General Electric sold out of SOPHiA GENETICS (SOPH) in Q1 2023, closing a stake of 1,111,111 shares — an estimated $2.29M sold.

General Electric first reported a position in SOPH in Q3 2021 and held it in 6 quarters. The position peaked at $19.5M in Q3 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q1 2023.

  • General Electric reported no remaining SOPHiA GENETICS position as of Q1 2023 after selling out during the quarter.
  • General Electric sold 1,111,111 SOPHiA GENETICS shares in Q1 2023, an estimated $2.29M.
  • General Electric first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 6 quarters.
  • General Electric's SOPHiA GENETICS position peaked at $19.5M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2023.

Based on General Electric's 13F filing for Q1 2023, filed 15 May 2023.